These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 437261)

  • 61. Selective decrease in the affinity of D2 dopamine receptor for agonist induced by islet-activating protein, pertussis toxin, associated with ADP-ribosylation of the specific membrane protein of bovine striatum.
    Kuno T; Shirakawa O; Tanaka C
    Biochem Biophys Res Commun; 1983 Aug; 115(1):325-30. PubMed ID: 6225433
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coupling of neurotransmitter receptors with an adenylate cyclase. A tool for studying their pharmacological properties, distribution and modulation in the central nervous system.
    Bockaert J
    J Physiol (Paris); 1978; 74(5):527-33. PubMed ID: 218000
    [No Abstract]   [Full Text] [Related]  

  • 63. Conformation of dopamine at the dopamine receptor.
    Komiskey HL; Bossart JF; Miller DD; Patil PN
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2641-3. PubMed ID: 275833
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 66. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
    Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatum.
    Członkowski A; Höllt V; Herz A
    Life Sci; 1978 Mar; 22(11):953-62. PubMed ID: 205747
    [No Abstract]   [Full Text] [Related]  

  • 68. Changes in striatal specific 3-H-atropine binding after unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurones.
    Kato G; Carson S; Kemel ML; Glowinski J; Giorguieff MF
    Life Sci; 1978 May; 22(18):1607-14. PubMed ID: 353416
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M; Dobrovský K; Krejcí I; Dlabac A
    Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
    [No Abstract]   [Full Text] [Related]  

  • 70. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M; Totaro JA
    Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum.
    Schoemaker H; Langer SZ
    Eur J Pharmacol; 1986 May; 124(3):371-3. PubMed ID: 2942413
    [No Abstract]   [Full Text] [Related]  

  • 73. 5-Hydroxytryptamine binding to synaptic membranes from rat brain.
    Fillion G; Fillion MP; Spirakis C; Bahers JM; Jacob J
    Life Sci; 1976 Jan; 18(1):65-74. PubMed ID: 2829
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 3H-Haloperidol binding to tissue receptors: influence of some drugs and antipsychotic potency.
    Fulton A; Burrows GD
    Life Sci; 1980 May; 26(18):1505-8. PubMed ID: 6104764
    [No Abstract]   [Full Text] [Related]  

  • 76. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

  • 77. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors.
    Sokoloff P; Martres MP; Schwartz JC
    Nature; 1980 Nov; 288(5788):283-6. PubMed ID: 7432527
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Demonstration of a complex subunit composition of a unitary dopamine receptor: effects of lesions and proteolytic enzymes on stereospecific binding.
    Leysen JE; Gommeren W; Van Gompel P
    Adv Biochem Psychopharmacol; 1983; 36():147-62. PubMed ID: 6858752
    [No Abstract]   [Full Text] [Related]  

  • 79. Benzazepines: structure-activity relationships between D1 receptor blockade and selected pharmacological effects.
    Iorio LC; Barnett A; Billard W; Gold EH
    Adv Exp Med Biol; 1986; 204():1-14. PubMed ID: 2947422
    [No Abstract]   [Full Text] [Related]  

  • 80. Ontogeny of dopamine D1 receptors in rat striatum.
    Zeng WY; Hyttel J; Murrin LC
    J Neurochem; 1988 Mar; 50(3):862-7. PubMed ID: 2963092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.